Physician profile
Meredith C Treece
NPI 1821307760
$5,398.95
in general payments reported to CMS, 2019-2025
21 companies · $885 in 2025
The $885 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $309 · 2021: $702 · 2022: $1,084 · 2023: $1,074 · 2024: $871 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,830.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,431.67 | 2019-2025 | Total30, Precision7, Tryptyr |
| Coopervision INC. | $702.91 | 2019-2025 | Myday Contact Lens, Synergeyes Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $347.33 | 2022-2025 | Envista Aspire Iol, Infuse, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $330.98 | 2019-2021 | |
| Topcon Healthcare, INC. | $234.88 | 2023-2024 | |
| Johnson & Johnson Vision Care, INC. | $190.06 | 2023-2025 | Acuvue |
| Oyster Point Pharma, INC. | $186.49 | 2022-2025 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $175.33 | 2022-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $165.21 | 2019-2024 | Cequa |
| Kala Pharmaceuticals, INC. | $154.83 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $147.04 | 2022 | |
| Allergan, INC. | $87.15 | 2019-2022 | |
| Notal Vision, INC. | $79.71 | 2024 | Foresee Home |
| Biotissue Holdings INC. | $29.66 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $29.25 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $19.41 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Amgen INC. | $18.30 | 2024 | Tepezza |
| Eyevance Pharmaceuticals LLC | $17.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.51 | 2019 | |
| Sight Sciences, INC. | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Treece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.